Focus on: TTIP & intellectual property
Behind the bluster about “getting Brexit done” is an ambitious long term agenda: to realign our economy and our standards with the interests of American business.
The mutual recognition agreement for inspections of manufacturing sites for human medicines in their respective territories can make it faster and less costly for both sides to bring medicines to the market.
In its latest report on foreign trade barriers, the USTR, prompted by the pharmaceutical industry, takes aim at the pharmaceutical pricing and reimbursement policies in the European Union.
The European Parliament adopted a resolution to suspend the EU-US Privacy Shield agreement, saying the US’ compliance efforts to date “fail to provide enough data protection for EU citizens.”
British microbiologists find that American technique at heart of Brexit trade row does not kill listeria and salmonella
If the world’s three major economies the US, the EU, and China were ever to harmonise their approach to regulating digital trade and global data flows, the pressure on developing countries to accept digital rules would intensify.
If we can manage our own economies well, new trade pacts will become largely redundant.
How to achieve data protection-proof free trade agreements?
The French Government calls on the European Commission to adopt an open and innovation-friendly data flow system while preserving European interests in trade agreements
’Unfortunately, trade agreements have become one more mechanism for drug corporations to expand their monopoly power’
Big Pharma is everything but shy when it comes to lobbying EU policy-makers. But what exactly are these groups lobbying for in TTIP?
In June, the European Commission broke its promise that it will not trade away the ’precautionary principle’ to strike a trade deal with the United States, BEUC reports.
The purpose of the study was to have an independent assessment on the respect of privacy and data protection by trade agreements being negotiated by the European Union.
The Transatlantic Trade and Investment Treaty (TTIP) may present a genuine threat to health and to the outcomes we have reached in the healthcare systems today.
The controversial Transatlantic Trade and Investment Partnership (TTIP) will have negative effects on public health, jobs and the climate, according to the official impact assessment.
New working paper highlights the potential harmful impact of CETA and TTIP (and other trade and investment agreements) on healthcare and social services.
As welcome as the leak is, it doesn’t fix these systemic flaws in the process of negotiating trade agreements such as TTIP and the TPP.
Private arbitral tribunals will be able to impose multi-million fines on States whose parliaments have dared to legislate without taking into account corporate expectations.
One element of TTIP has been largely ignored – the deal’s impact on developing countries.
Progress was made in the latest round of TTIP talks, but negotiators have a long way to go if the deal is to be signed before Barack Obama leaves office.
